Cingulate
CING • NASDAQ
Cingulate is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Shane J. Schaffer, with a market cap of $74.3M.
CEOShane J. Schaffer
Next Earnings
Upcoming earnings announcement for Cingulate
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.44
Earnings History
Past 12 earnings reports for Cingulate
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 18, 2026 | Q4 2025 | -$0.84Est: -$1.15 | +27.0% | - | — | — |
| Nov 13, 2025 | Q3 2025 | -$1.35Est: -$0.77 | -75.3% | - | — |  10-Q |
| Aug 19, 2025 | Q2 2025 | -$1.09Est: -$0.82 | -32.9% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$1.04Est: -$0.96 | -8.3% | - | — | 10-Q |
| Mar 26, 2025 | Q4 2024 | -$0.14Est: -$1.49 | +90.6% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$1.83Est: -$2.36 | +22.5% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$5.47Est: -$5.64 | +3.0% | - | — | 10-Q |
| May 8, 2024 | Q1 2024 | -$7.20Est: -$14.04 | +48.7% | - | — | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$33.60Est: -$58.32 | +42.4% | - | — | — |
| Nov 13, 2023 | Q3 2023 | -$72.00Est: -$91.20 | +21.1% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$136.80Est: -$84.00 | -62.9% | - | — | 10-Q |
| May 10, 2023 | Q1 2023 | -$84.00Est: -$81.60 | -2.9% | - | — | 10-Q |